P, K., SV, C., JC, G., MB, G., S, H., MS, A., . . . MG, C. (2021). Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice. The Journal of clinical investigation, 131(4), . https://doi.org/10.1172/JCI139542
Chicago Style (17th ed.) CitationP, Kadiyala, et al. "Inhibition of 2-hydroxyglutarate Elicits Metabolic Reprogramming and Mutant IDH1 Glioma Immunity in Mice." The Journal of Clinical Investigation 131, no. 4 (2021). https://doi.org/10.1172/JCI139542.
MLA (9th ed.) CitationP, Kadiyala, et al. "Inhibition of 2-hydroxyglutarate Elicits Metabolic Reprogramming and Mutant IDH1 Glioma Immunity in Mice." The Journal of Clinical Investigation, vol. 131, no. 4, 2021, https://doi.org/10.1172/JCI139542.